Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue    
Total revenue, net $ 34,409 $ 21,625
Operating expenses    
Cost of sales 421 256
Selling, general and administrative 50,124 45,197
Research and development 13,158 12,620
Other expense, net 290 1,434
Total cost of sales and operating expenses 63,993 59,507
Loss from operations (29,584) (37,882)
Interest income 3,814 262
Net loss before income taxes (25,770) (37,620)
Income tax expense 436 10
Net loss (26,206) (37,630)
Other comprehensive loss:    
Unrealized gain (loss) on available-for-sale securities, net of tax of nil 73 (766)
Comprehensive loss $ (26,133) $ (38,396)
Basic loss per share ($ per share) $ (0.18) $ (0.27)
Diluted loss per share ($ per share) $ (0.18) $ (0.27)
Weighted-average common shares outstanding used in computation of basic loss per share (in shares) 142,641 141,675
Weighted average common shares outstanding diluted (in shares) 142,641 141,675
Product revenue, net    
Revenue    
Total revenue, net $ 34,337 $ 21,492
License, royalty and collaboration revenue    
Revenue    
Total revenue, net $ 72 $ 133